Physicist Lee Smolin said, “Science moves fastest when there’s plenty of debate and controversy.”
For the second straight year, an Oxford-style debate is on the program for the San Antonio Breast Cancer Symposium® (SABCS®) Dec. 4-8.
Friday morning, Dec. 7, Daniel Hayes, MD, FASCO, FACP of the University of Michigan, Ann Arbor (left) will debate Harold Burstein, MD, PhD of the Dana-Farber Cancer Institute in Boston (right) on the topic, “Should All Women with Breast Cancer and Positive Lymph Nodes Receive Chemotherapy?” Clifford A. Hudis, MD of the American Society of Clinical Oncology in Alexandria, Virginia will moderate.
“The debates are a lot of fun because they allow the audience to participate and they are extremely clinically relevant,” said SABCS Co-Director, Virginia Kaklamani, MD, professor of medicine, Division of Hematology/Oncology, UT Health San Antonio. “They’re done in a fun way so that the two people that are reviewing the topics are kind of competing against each other and the audience is participating in the competition.”
In an Oxford-style debate, the audience is polled regarding its position on the topic. They are polled again at the end of the debate to see which participant was most persuasive in their arguments.
The debate will be in Hall 3 at 9 a.m., Friday, Dec. 7.
Categories: | Tags: | View Count: (3471) | Return